"The main focus of our lab is to study the mechanisms that underlie mammalian pancreas organogenesis and pancreatic diseases, including diabetes and pancreatic cancer. We regularly use both Accutase and Accumax in cell culture and FACS applications using human embryonic stem cells and human induced pluripotent stem cells because these products give the best cell dissociation without compromising the health of our cells." 

- Jennifer Ringler, Staff Research Associate, Hebrok Lab, UCSD

Find out which ICT Product is Right for You:

Accutase 
Cell Detachment Solution
Accutase is a ready to use, replacement for trypsin.  It requires less steps and results in healthier cells.  Accutase is the only cell detachment solution on the market gentle enough to work on stem cells. 
AccutaseLZ 
Lyophilized Accutase
AccutaseLZ is the powder form of our ever-popular Accutase, and is convenient for international customers in difficult shipping situations.  Easy to reconstitute, equally effective.
Accumax 
Cell Dissociation Solution
Accumax is a gentle enzyme mixture similar to Accutase, but powerful enough to dissociate tissue, dissolve spheroids, and eliminate clumps  and extend flow cytometry sorts without harming your cells.  
AccutaseGMP 
Highly Characterized Accutase 
AccutaseGMP is a more highly purified version of Accutase for use in the development of all stem cell therapies, vaccines, and any biopharmaceutical project needing reagents conforming to regulatory requirements. 

Check out the Product Guide for more info on all four ICT products.

Sorting cells on a flow cytometer?

Save on Price, Shipping, and Storage with Cheap Sheath 

Flow Cytometer Sheath Fluid Concentrate

www.cheapsheath.com

The Latest Publications Using
Accutase & Accumax

2/19/14
The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation
Anita S. Bledau, Kerstin Schmidt, Katrin Neumann, Undine Hill, Giovanni Ciotta, Ashish Gupta, Davi Coe Torres, Jun Fu, Andrea Kranz, A. Francis Stewart, and Konstantinos Anastassiadis
Development. 2014; 141:1022-1035.  Abstract | Full Text | PDF
2/18/14
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas
Irene Ischenko, Oleksi Petrenko, and Michael J. Hayman
PNAS. published 18 February 2014, 10.1073/pnas.1319911111  Abstract | PDF
1/24/14
Epigenetic Regulation of miR-302 by JMJD1C Inhibits Neural Differentiation of Human Embryonic Stem Cells
Jianle Wang, Jung W. Park, Hicham Drissi, Xiaofang Wang, and Ren-He Xu
J. Biol. Chem. 2014; 289:2384-2395.  Abstract | Full Text | PDF

Innovative Cell Technologies 
is a member of